Both in Biotechnology
Dyadic International vs Jasper Therapeutics
Over the past year DYAI returned −66.5% and JSPR returned −74.0%; their daily moves had a correlation of 0.16.
DYAI −66.5% JSPR −74.0%Growth of $1, one year, split-adjusted
| Metric | DYAI | JSPR |
|---|---|---|
| Price | $0.3667 | $0.5111 |
| Market cap | $14.7M | $17.0M |
| Today | +1.86% | +6.48% |
| 1 month | −19.1% | −8.7% |
| 6 months | −51.8% | −46.0% |
| Year to date | −61.0% | −72.1% |
| 1 year | −66.0% | −75.7% |
| Revenue growth (YoY) | −0.6% | — |
| Gross margin | −2.4% | — |
| Net margin | −221.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | — |
| Net cash | -$1.9M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 76.8% | 75.7% |
| Short % of float | 0.7% | 22.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).